Share This Page
Drug Price Trends for SORE THROAT
✉ Email this page to a colleague
Average Pharmacy Cost for SORE THROAT
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SORE THROAT 1.4% SPRAY | 70000-0458-01 | 0.01313 | ML | 2024-12-18 |
| SORE THROAT 15-3.6 MG LOZENGE | 00904-6255-49 | 0.15701 | EACH | 2024-12-18 |
| SORE THROAT 1.4% SPRAY | 46122-0278-30 | 0.01313 | ML | 2024-12-18 |
| SORE THROAT 1.4% SPRAY | 00904-6305-21 | 0.01313 | ML | 2024-12-18 |
| SORE THROAT 1.4% SPRAY | 46122-0265-30 | 0.01313 | ML | 2024-12-18 |
| SORE THROAT 1.4% SPRAY | 00904-6305-21 | 0.01311 | ML | 2024-11-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Sore Throat Remedies Market Analysis and Price Projections
Introduction to Sore Throat Remedies
Sore throat remedies are a crucial segment within the broader cold, cough, and sore throat remedies market. These remedies include a variety of products such as lozenges, syrups, tablets, and nasal drops designed to provide relief from sore throats caused by viral or bacterial infections.
Market Size and Growth Projections
The market for sore throat remedies is experiencing significant growth driven by several key factors.
- Global Market Size: The throat lozenges market, a key component of sore throat remedies, was valued at approximately USD 5.16 billion in 2023 and is projected to reach USD 7.25 billion by 2031, growing at a CAGR of 5.4% from 2024 to 2031[2].
- Expanded Forecast: Another report indicates that the throat lozenges market could reach as high as USD 9.8 billion by 2034, growing at a CAGR of 5.1% from 2024 to 2034[5].
Regional Analysis
The demand for sore throat remedies varies significantly across different regions.
- Asia Pacific: This region dominates the market for cold, cough, and sore throat remedies, including sore throat treatments. The rising consumer disposable income, increased awareness of these products, and preference for natural treatments are key drivers in this region[1].
- United States: The U.S. market is highly lucrative due to its advanced healthcare infrastructure and strong pharmaceutical sector. The market value in the U.S. is expected to grow from USD 1.94 billion in 2024 to USD 3.46 billion by 2034, at a CAGR of 6%[5].
- South Korea: In South Korea, the integration of traditional formulas with modern medicine is expected to boost the sales of innovative throat lozenges. The market is projected to grow from USD 242.1 million in 2024 to USD 408.3 million by 2034, at a CAGR of 5.4%[5].
Distribution Channels
The distribution channels for sore throat remedies are diverse and play a crucial role in market growth.
- Retail Pharmacies: Retail pharmacies and drug stores are significant distribution channels. The demand for pharyngitis treatment products through these channels is projected to increase at a CAGR of 3.9% and reach a value of USD 1.22 billion by 2034[3].
- E-Commerce/Online Pharmacies: Online pharmacies are also gaining traction, offering convenience and accessibility, which is expected to drive market growth[1].
Product Segments
Sore throat remedies come in various forms, each with its own market dynamics.
- Throat Lozenges: Lozenges are a popular form of sore throat remedy. They are expected to hold a high global market share over the forecast period, with a projected value of USD 5.21 billion by 2034, growing at a CAGR of 5.2%[5].
- Oral Syrups and Tablets: Other forms like oral syrups and tablets also contribute significantly to the market. These products are often preferred for their quick relief and ease of use[1].
Drivers and Restraints
Several factors drive and restrain the market for sore throat remedies.
- Drivers: Rising prevalence of throat diseases, increasing government spending on healthcare, and the availability of a diverse range of product options are key drivers. Additionally, the integration of traditional formulas with modern medicine and advancements in treatment methods contribute to market growth[3][5].
- Restraints: Concerns about side effects and safety, generic competition, and seasonal demand fluctuations are major restraints. Recall and failure of products can also hamper market growth[1].
Price Projections
The prices of sore throat remedies are influenced by various factors including production costs, market demand, and competition.
- Throat Lozenges: Given the projected growth, the average price of throat lozenges is likely to remain competitive. However, premium and innovative products may see higher price points due to their advanced formulations and benefits[5].
- Overall Market: The overall market for cold, cough, and sore throat remedies, including sore throat treatments, is expected to grow from USD 41.22 billion in 2023 to USD 56.17 billion by 2032. This growth suggests that prices will likely stabilize or increase slightly due to increased demand and innovation[1].
Key Players
Several prominent players dominate the market for sore throat remedies.
- Reckitt Benckiser, Group PLC
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc
- Novartis AG
- Bayer AG
- AstraZeneca plc
These companies are investing heavily in R&D to improve their product offerings and maintain market share[1].
Conclusion
The market for sore throat remedies is poised for significant growth driven by increasing prevalence of throat diseases, advancements in treatment methods, and the availability of diverse product options. While concerns about side effects and generic competition pose challenges, the overall outlook remains positive.
Key Takeaways
- The throat lozenges market is expected to grow from USD 5.16 billion in 2023 to USD 7.25 billion by 2031.
- The Asia Pacific region dominates the market due to rising consumer disposable income and increased awareness.
- The U.S. market is driven by advanced healthcare infrastructure and a strong pharmaceutical sector.
- Throat lozenges are expected to hold a high global market share, with a projected value of USD 5.21 billion by 2034.
- Concerns about side effects and safety, along with generic competition, are major restraints.
FAQs
Q: What is the projected growth rate of the throat lozenges market from 2024 to 2031? A: The throat lozenges market is projected to grow at a CAGR of 5.4% from 2024 to 2031[2].
Q: Which region dominates the market for cold, cough, and sore throat remedies? A: The Asia Pacific region dominates the market for cold, cough, and sore throat remedies[1].
Q: What are the primary drivers of the sore throat remedies market? A: The primary drivers include rising prevalence of throat diseases, increasing government spending on healthcare, and the availability of a diverse range of product options[3][5].
Q: Which distribution channels are significant for sore throat remedies? A: Retail pharmacies, drug stores, and e-commerce/online pharmacies are significant distribution channels[1][3].
Q: What is the expected market value of the U.S. throat lozenges market by 2034? A: The U.S. throat lozenges market is expected to reach USD 3.46 billion by 2034, growing at a CAGR of 6% from 2024 to 2034[5].
Sources
- Cold, Cough, & Sore Throat Remedies Market Size Report 2032 - SNS Insider
- Sore Throat Lozenges Market Size, Share, Scope & Forecast - Verified Market Research
- Pharyngitis Market Size & Industry Share | Statistics By 2034 - Fact.MR
- Throat Lozenges Market Size, Trends & Forecast | 2032 - SkyQuest
- Throat Lozenges Market Size & Growth | Demand Analysis, 2034 - Fact.MR
More… ↓
